HHS Secretary Alex Azar has been reportedly discussing the removal of Dr. Stephen Hahn as FDA commissioner, according to Politico.
The Politico report cited a half dozen current and former administration officials.
FDA spokesperson Michael Felberbaum in an email to Drug Discovery‘s sister site MassDevice denied an Azar-Hahn feud: “Commissioner Hahn enjoys a good relationship with Secretary Azar and speaks with him regularly.”
Politico‘s claim of a potential Hahn ouster comes after FDA openly defied President Donald Trump by telling COVID-19 vaccine developers that the agency needs two months’ worth of safety data before it will consider emergency approvals.
Filed Under: Drug Discovery, Infectious Disease